These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30487058)

  • 1. One quarter of total myocardial infarctions are silent manifestation in patients with type 2 diabetes mellitus.
    Soejima H; Ogawa H; Morimoto T; Okada S; Sakuma M; Nakayama M; Masuda I; Doi N; Uemura S; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
    J Cardiol; 2019 Jan; 73(1):33-37. PubMed ID: 30487058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.
    Ogawa H; Nakayama M; Morimoto T; Uemura S; Kanauchi M; Doi N; Jinnouchi H; Sugiyama S; Saito Y;
    JAMA; 2008 Nov; 300(18):2134-41. PubMed ID: 18997198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose aspirin therapy in patients with type 2 diabetes and reduced glomerular filtration rate: subanalysis from the JPAD trial.
    Saito Y; Morimoto T; Ogawa H; Nakayama M; Uemura S; Doi N; Jinnouchi H; Waki M; Soejima H; Sugiyama S; Okada S; Akai Y;
    Diabetes Care; 2011 Feb; 34(2):280-5. PubMed ID: 21270185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.
    Davis TM; Coleman RL; Holman RR;
    Circulation; 2013 Mar; 127(9):980-7. PubMed ID: 23362315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin possibly reduces cerebrovascular events in type 2 diabetic patients with higher C-reactive protein level: subanalysis from the JPAD trial.
    Soejima H; Ogawa H; Morimoto T; Nakayama M; Okada S; Sakuma M; Uemura S; Kanauchi M; Doi N; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
    J Cardiol; 2013 Sep; 62(3):165-70. PubMed ID: 23778008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex Difference in Effects of Low-Dose Aspirin on Prevention of Dementia in Patients With Type 2 Diabetes: A Long-term Follow-up Study of a Randomized Clinical Trial.
    Matsumoto C; Ogawa H; Saito Y; Okada S; Soejima H; Sakuma M; Masuda I; Nakayama M; Doi N; Jinnouchi H; Waki M; Morimoto T; ;
    Diabetes Care; 2020 Feb; 43(2):314-320. PubMed ID: 31801787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinuria is independently associated with the incidence of primary cardiovascular events in diabetic patients.
    Soejima H; Ogawa H; Morimoto T; Okada S; Matsumoto C; Nakayama M; Masuda I; Jinnouchi H; Waki M; Saito Y;
    J Cardiol; 2020 Apr; 75(4):387-393. PubMed ID: 31564388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of low-dose aspirin for primary prevention of atherosclerotic events in diabetes management: a subanalysis of the JPAD trial.
    Okada S; Morimoto T; Ogawa H; Kanauchi M; Nakayama M; Uemura S; Doi N; Jinnouchi H; Waki M; Soejima H; Sakuma M; Saito Y;
    Diabetes Care; 2011 Jun; 34(6):1277-83. PubMed ID: 21515838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial.
    Saito Y; Okada S; Ogawa H; Soejima H; Sakuma M; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Morimoto T;
    Circulation; 2017 Feb; 135(7):659-670. PubMed ID: 27881565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial.
    Lopes RD; Leonardi S; Neely B; Neely ML; Ohman EM; Ardissino D; Hamm CW; Goodman SG; Bhatt DL; White HD; Prabhakaran D; Martinez F; Nicolau JC; Winters KJ; Fox KA; Armstrong PW; Roe MT
    J Am Coll Cardiol; 2016 Mar; 67(11):1289-97. PubMed ID: 26988949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silent Myocardial Infarction and Long-Term Risk of Heart Failure: The ARIC Study.
    Qureshi WT; Zhang ZM; Chang PP; Rosamond WD; Kitzman DW; Wagenknecht LE; Soliman EZ
    J Am Coll Cardiol; 2018 Jan; 71(1):1-8. PubMed ID: 29301615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin reduces cerebrovascular events in type 2 diabetic patients with poorly controlled blood pressure. Subanalysis from the JPAD trial.
    Soejima H; Ogawa H; Morimoto T; Nakayama M; Okada S; Uemura S; Kanauchi M; Doi N; Sakuma M; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
    Circ J; 2012; 76(6):1526-32. PubMed ID: 22447019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study.
    Erdmann E; Dormandy JA; Charbonnel B; Massi-Benedetti M; Moules IK; Skene AM;
    J Am Coll Cardiol; 2007 May; 49(17):1772-80. PubMed ID: 17466227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel and Practical Screening Tool for the Detection of Silent Myocardial Infarction in Patients With Type 2 Diabetes.
    Swoboda PP; McDiarmid AK; Erhayiem B; Haaf P; Kidambi A; Fent GJ; Dobson LE; Musa TA; Garg P; Law GR; Kearney MT; Barth JH; Ajjan R; Greenwood JP; Plein S
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3316-23. PubMed ID: 27300573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is silent myocardial infarction more common in women with type 2 diabetes than in men?
    Stiles MC; Seaquist ER; Yale JF; Green JB; Katz LA; Kempainen S; Light LS; Pepper PV; Zhang ZM; Soliman EZ
    J Diabetes Complications; 2012; 26(2):118-22. PubMed ID: 22446034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Hazard of Myocardial Infarction With Insulin-Provision Therapy in Actively Smoking Patients With Diabetes Mellitus and Stable Ischemic Heart Disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Trial.
    Khan AA; Chung MJ; Novak E; Brown DL
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28903941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose aspirin for primary prevention of cardiovascular disease.
    Bredie SJ; Wollersheim H; Verheugt FW; Thien T
    Semin Vasc Med; 2003 May; 3(2):177-84. PubMed ID: 15199480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A large frontal QRS-T angle is a strong predictor of the long-term risk of myocardial infarction and all-cause mortality in the diabetic population.
    May O; Graversen CB; Johansen MØ; Arildsen H
    J Diabetes Complications; 2017 Mar; 31(3):551-555. PubMed ID: 28065667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evidence for Japanese population based on prospective studies--linking clinical trials and clinical practice.
    Ogawa H; Kojima S
    J Cardiol; 2009 Oct; 54(2):171-82. PubMed ID: 19782253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.